跳至主要内容
临床试验/CTRI/2012/05/002677
CTRI/2012/05/002677已完成4 期

Effect of probiotic and zinc supplementation on systemic immune response to oral rotavirus and oral poliovirus vaccination

Department of Biotechnology1 个研究点 分布在 1 个国家目标入组 560 人开始时间: 2012年2月7日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
560
试验地点
1
主要终点
•To evaluate the serologic immune response to rotavirus vaccine among Indian infants receiving zinc supplementation or a probiotic given daily for a week prior to the first dose through a week following the second dose of oral rotavirus vaccine compared to those receiving a zinc or probiotic placebo

研究概览

简要总结

This single center,double blind, double-dummy, placebo controlled, randomized parallel clinicaltrial with four groups will enroll approximately 560 total study participantsat approximately 5 weeks of age residing in proximity to the Christian MedicalCollege in Vellore.  As part of theparallel design, study participants will be randomized to one of the fourgroups following a 1:1:1:1 allocation to receive zinc supplement and probiotic supplement(N=140), zinc supplement and probiotic placebo (N=140), zinc placebo andprobiotic supplement (N=140), or zinc placebo and probiotic placebo(N=140). Serum specimens collected at 6 and 14 weeks will be analyzed for anti-rotavirus IgA and for neutralizing antibodies to poliovirus type 3 in order to determine whether or not supplementation with probiotics and/or zinc can enhance the proportion of children who respond to oral vaccination by at least  15%.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Double Blind Double Dummy

入排标准

年龄范围
35.00 Day(s) 至 41.00 Day(s)(—)
性别
All

入选标准

  • •Infants 35-41 days old.
  • •Live in area under surveillance.
  • •Current weight ≥3.2 kg.
  • •No syndromic evidence of immunocompromise.
  • •No prior illness requiring hospitalization.
  • •No current medical condition as determined by medical doctor which precludes study involvement.
  • •Available for follow up for duration of study (through approximately 14 weeks of age).
  • •Parents/guardians of infant are able to understand and follow study procedures and agree to participate in the study by providing signed informed consent.

排除标准

  • •Child has history of atopic symptoms.
  • •Child has a known digestive system defect.
  • •Child has history of chronic diarrhea.
  • •Child has received a prior dose of rotavirus vaccine.
  • •Child has received a prior dose of polio vaccine (beyond the birth dose).

结局指标

主要结局

•To evaluate the serologic immune response to rotavirus vaccine among Indian infants receiving zinc supplementation or a probiotic given daily for a week prior to the first dose through a week following the second dose of oral rotavirus vaccine compared to those receiving a zinc or probiotic placebo

时间窗: 4 weeks after the second dose of immunization

次要结局

  • •To evaluate the serologic immune response to oral polio vaccine among Indian infants receiving zinc or probiotic supplementation given daily for a week prior to the administration of the first dose through a week following the second dose of oral polio vaccine compared to those receiving a zinc or probiotic placebo(4 weeks after the second dose of immunization)

研究者

发起方
Department of Biotechnology
申办方类型
Government funding agency

研究点 (1)

Loading locations...

相似试验